Implications of circulating chromogranin A in prostate cancer-Reference-Cited by-同舟云学术

Implications of circulating chromogranin A in prostate cancer

Published:2007-01-01 Issue:4 Volume:41 Page:297-301
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Hirano Daisaku¹,Minei Sadatsugu¹,Sugimoto Shuji¹,Yamaguchi Kenya¹,Yoshikawa Tetsuo¹,Hachiya Takahiko¹,Kawata Nozomu¹,Yoshida Toshio¹,Takahashi Satoru¹

Affiliation:

1. Department of Urology, Nihon University School of Medicine, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365590701303934

Reference26 articles.

1. Neuroendocrine differentiation in prostatic malignancy

2. The course of neuroendocrine differentiation in prostatic carcinomas

3. Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate

4. Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands

5. Neuroendocrine differentiation and the bombesin/gastrin-releasing peptide family of neuropeptides in the progression of human prostate cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase;Journal of Nuclear Medicine;2019-10-25

Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis

;Cancer Management and Research;2019-04

3. Prognostic role of chromogranin A in castration-resistant prostate cancer: A meta-analysis;Asian Journal of Andrology;2018

4. Prospective study on the relationship between clinical efficacy of secondary hormone therapy with flutamide and neuroendocrine differentiation in patients with relapsed prostate cancer after first line hormone therapy;Scandinavian Journal of Urology;2014-04-15

5. Serum levels of chromogranin A are not predictive of high-grade, poorly differentiated prostate cancer: Results from an Italian biopsy cohort;Urologic Oncology: Seminars and Original Investigations;2014-02